Who invested in AmyriAD?
One investor is on record as having backed AmyriAD — Phase 3 drug for Alzheimer's disease, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
amyriadtherapeutics.comAmyriAD investors
No round dates are on record for AmyriAD. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed AmyriAD are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.